Delivery Order SPE2DB22D3501-SPE2DB25FVY52
Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,193.89 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Remifentanil is a potent synthetic opioid analgesic commonly used in medical and surgical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Remifentanil 2 mg vials with a ceiling value of $1,675.46. The contract utilizes a firm fixed price structure and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,925.36 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This contract type represents a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,522.64 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This is a firm fixed price delivery order, effective through August 25, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Remifentanil is a potent synthetic opioid analgesic commonly used in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,315.50 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials, with an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and designates Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,983.47 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, a potent opioid analgesic commonly used in clinical and surgical settings. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials, valued at $7,489.63 under a firm fixed-price contract. The award was made on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials under a firm fixed-price contract. This award, issued on August 28, 2025, carries a ceiling value of $10,266.97 and is expected to reach ultimate completion on August 29, 2025. The contract is a non-set-aside, competitively awarded delivery order that leverages AmerisourceBergen's broader relationship with DLA to fulfill critical pharmaceutical needs. Performance will be...
- The Defense Logistics Agency awarded a $4,756.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of June 30, 2025. This non-set-aside contract was competitively awarded on June 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,317.05 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 1 mg vials of the pharmaceutical drug remifentanil. The contract has a completion date of February 1, 2024 and was awarded on January 31, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to support military treatment programs and facilities. This delivery...